According to the research report published by Market IntelliX, the global market for Recombinant Proteins should grow from US$ 975.8 million in 2022 to US$ 2320.6 million by 2029, with a CAGR of 13.0% for the period of 2023-2029.
Global key manufacturers of recombinant proteins are Bio-Techne Corporation, Abcam PLC, Merck KGaA, Miltenyi Biotec, Thermo Fisher Scientific, ACROBiosystems, Sino Biological, and others. The top six manufacturers together account for about 50% of the market share, with the largest manufacturer being Bio-Techne Corporation with 10%. In terms of market size, Asia Pacific is the largest consumption market with more than 35% share. In terms of product categories, cytokines hold the largest market share with 25%, followed by hormones and immune checkpoint regulators with 20% and 15% respectively. In terms of applications, biopharmaceutical companies are the top application area, with over 80% of the market share.
Recombinant protein is a manipulated form of protein encoded by recombinant DNA, which has been cloned in a foreign expression system to supports the expression of the exogenous gene. This recombinant DNA construct can be used to manufacture large quantities of useful protein products. The recombinant DNA, usually the cDNA sequence of the target protein, is designed to be under the control of a well-characterized promoter to express the target protein within the chosen host cell to achieve high-level protein expression.
This report aims to provide a comprehensive study of the global market for Recombinant Proteins. Report Highlights:
(1) Global Recombinant Proteins market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Recombinant Proteins market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Recombinant Proteins market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Recombinant Proteins segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Recombinant Proteins segment by type and by application and regional segment by type and by application.
(6) Recombinant Proteins industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Hormones
Growth Factors
Cytokines
Plasma Protein Factor
Recombinant Metabolic Enzymes
Immune Checkpoint Regulators
Others
Market segment by application, can be divided into
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Market segment by players, this report covers
Bio-Techne Corporation
Abcam PLC
Merck KGaA
Miltenyi Biotec
Thermo Fisher Scientific
ACROBiosystems
Sino Biological
Cytiva
Eurogentec
GenScript Biotech Corporation
Reprocell
BPS Bioscience
Abnova Corporation
ProSpec Tany TechnoGene
Ajinomoto
1 Market Overview
1.1 Product Overview and Scope of Recombinant Proteins
1.2 Global Recombinant Proteins Market Size and Forecast
1.3 China Recombinant Proteins Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Recombinant Proteins Share in Global Market, 2018-2029
1.4.2 Recombinant Proteins Market Size: China VS Global, 2018-2029
1.5 Recombinant Proteins Market Dynamics
1.5.1 Recombinant Proteins Market Drivers
1.5.2 Recombinant Proteins Market Restraints
1.5.3 Recombinant Proteins Industry Trends
1.5.4 Recombinant Proteins Industry Policy
2 Global Competitive Situation by Company
2.1 Global Recombinant Proteins Revenue by Company (2018-2023)
2.2 Global Recombinant Proteins Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Recombinant Proteins Concentration Ratio
2.4 Global Recombinant Proteins Mergers & Acquisitions, Expansion Plans
2.5 Global Recombinant Proteins Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Recombinant Proteins Revenue by Company (2018-2023)
3.2 China Recombinant Proteins Recombinant Proteins Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Recombinant Proteins, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Recombinant Proteins Industry Chain
4.2 Recombinant Proteins Upstream Analysis
4.3 Recombinant Proteins Midstream Analysis
4.4 Recombinant Proteins Downstream Analysis
5 Sights by Type
5.1 Recombinant Proteins Classification
5.1.1 Hormones
5.1.2 Growth Factors
5.1.3 Cytokines
5.1.4 Plasma Protein Factor
5.1.5 Recombinant Metabolic Enzymes
5.1.6 Immune Checkpoint Regulators
5.1.7 Others
5.2 By Type, Global Recombinant Proteins Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Recombinant Proteins Revenue, 2018-2029
6 Sights by Application
6.1 Recombinant Proteins Segment by Application
6.1.1 Biopharmaceutical Companies
6.1.2 Academic and Research Institutes
6.1.3 Contract Research Organizations
6.2 By Application, Global Recombinant Proteins Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Recombinant Proteins Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Recombinant Proteins Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Recombinant Proteins Market Size, 2018-2029
7.3 North America
7.3.1 North America Recombinant Proteins Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Recombinant Proteins Market Size Market Share
7.4 Europe
7.4.1 Europe Recombinant Proteins Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Recombinant Proteins Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Recombinant Proteins Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Recombinant Proteins Market Size Market Share
7.6 South America
7.6.1 South America Recombinant Proteins Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Recombinant Proteins Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Recombinant Proteins Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Recombinant Proteins Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Recombinant Proteins Market Size, 2018-2029
8.3.2 By Company, U.S. Recombinant Proteins Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Recombinant Proteins Market Size, 2018-2029
8.4.2 By Company, Europe Recombinant Proteins Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Recombinant Proteins Market Size, 2018-2029
8.5.2 By Company, China Recombinant Proteins Revenue Market Share, 2018-2023
8.5.3 By Type, China Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Recombinant Proteins Market Size, 2018-2029
8.6.2 By Company, Japan Recombinant Proteins Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Recombinant Proteins Market Size, 2018-2029
8.7.2 By Company, South Korea Recombinant Proteins Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Recombinant Proteins Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Recombinant Proteins Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Recombinant Proteins Market Size, 2018-2029
8.9.2 By Company, India Recombinant Proteins Revenue Market Share, 2018-2023
8.9.3 By Type, India Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Recombinant Proteins Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Recombinant Proteins Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Recombinant Proteins Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Recombinant Proteins Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Bio-Techne Corporation
9.1.1 Bio-Techne Corporation Company Information, Head Office, Market Area and Industry Position
9.1.2 Bio-Techne Corporation Company Profile and Main Business
9.1.3 Bio-Techne Corporation Recombinant Proteins Models, Specifications and Application
9.1.4 Bio-Techne Corporation Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.1.5 Bio-Techne Corporation Recent Developments
9.2 Abcam PLC
9.2.1 Abcam PLC Company Information, Head Office, Market Area and Industry Position
9.2.2 Abcam PLC Company Profile and Main Business
9.2.3 Abcam PLC Recombinant Proteins Models, Specifications and Application
9.2.4 Abcam PLC Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.2.5 Abcam PLC Recent Developments
9.3 Merck KGaA
9.3.1 Merck KGaA Company Information, Head Office, Market Area and Industry Position
9.3.2 Merck KGaA Company Profile and Main Business
9.3.3 Merck KGaA Recombinant Proteins Models, Specifications and Application
9.3.4 Merck KGaA Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.3.5 Merck KGaA Recent Developments
9.4 Miltenyi Biotec
9.4.1 Miltenyi Biotec Company Information, Head Office, Market Area and Industry Position
9.4.2 Miltenyi Biotec Company Profile and Main Business
9.4.3 Miltenyi Biotec Recombinant Proteins Models, Specifications and Application
9.4.4 Miltenyi Biotec Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.4.5 Miltenyi Biotec Recent Developments
9.5 Thermo Fisher Scientific
9.5.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
9.5.2 Thermo Fisher Scientific Company Profile and Main Business
9.5.3 Thermo Fisher Scientific Recombinant Proteins Models, Specifications and Application
9.5.4 Thermo Fisher Scientific Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.5.5 Thermo Fisher Scientific Recent Developments
9.6 ACROBiosystems
9.6.1 ACROBiosystems Company Information, Head Office, Market Area and Industry Position
9.6.2 ACROBiosystems Company Profile and Main Business
9.6.3 ACROBiosystems Recombinant Proteins Models, Specifications and Application
9.6.4 ACROBiosystems Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.6.5 ACROBiosystems Recent Developments
9.7 Sino Biological
9.7.1 Sino Biological Company Information, Head Office, Market Area and Industry Position
9.7.2 Sino Biological Company Profile and Main Business
9.7.3 Sino Biological Recombinant Proteins Models, Specifications and Application
9.7.4 Sino Biological Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.7.5 Sino Biological Recent Developments
9.8 Cytiva
9.8.1 Cytiva Company Information, Head Office, Market Area and Industry Position
9.8.2 Cytiva Company Profile and Main Business
9.8.3 Cytiva Recombinant Proteins Models, Specifications and Application
9.8.4 Cytiva Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.8.5 Cytiva Recent Developments
9.9 Eurogentec
9.9.1 Eurogentec Company Information, Head Office, Market Area and Industry Position
9.9.2 Eurogentec Company Profile and Main Business
9.9.3 Eurogentec Recombinant Proteins Models, Specifications and Application
9.9.4 Eurogentec Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.9.5 Eurogentec Recent Developments
9.10 GenScript Biotech Corporation
9.10.1 GenScript Biotech Corporation Company Information, Head Office, Market Area and Industry Position
9.10.2 GenScript Biotech Corporation Company Profile and Main Business
9.10.3 GenScript Biotech Corporation Recombinant Proteins Models, Specifications and Application
9.10.4 GenScript Biotech Corporation Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.10.5 GenScript Biotech Corporation Recent Developments
9.11 Reprocell
9.11.1 Reprocell Company Information, Head Office, Market Area and Industry Position
9.11.2 Reprocell Company Profile and Main Business
9.11.3 Reprocell Recombinant Proteins Models, Specifications and Application
9.11.4 Reprocell Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.11.5 Reprocell Recent Developments
9.12 BPS Bioscience
9.12.1 BPS Bioscience Company Information, Head Office, Market Area and Industry Position
9.12.2 BPS Bioscience Company Profile and Main Business
9.12.3 BPS Bioscience Recombinant Proteins Models, Specifications and Application
9.12.4 BPS Bioscience Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.12.5 BPS Bioscience Recent Developments
9.13 Abnova Corporation
9.13.1 Abnova Corporation Company Information, Head Office, Market Area and Industry Position
9.13.2 Abnova Corporation Company Profile and Main Business
9.13.3 Abnova Corporation Recombinant Proteins Models, Specifications and Application
9.13.4 Abnova Corporation Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.13.5 Abnova Corporation Recent Developments
9.14 ProSpec Tany TechnoGene
9.14.1 ProSpec Tany TechnoGene Company Information, Head Office, Market Area and Industry Position
9.14.2 ProSpec Tany TechnoGene Company Profile and Main Business
9.14.3 ProSpec Tany TechnoGene Recombinant Proteins Models, Specifications and Application
9.14.4 ProSpec Tany TechnoGene Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.14.5 ProSpec Tany TechnoGene Recent Developments
9.15 Ajinomoto
9.15.1 Ajinomoto Company Information, Head Office, Market Area and Industry Position
9.15.2 Ajinomoto Company Profile and Main Business
9.15.3 Ajinomoto Recombinant Proteins Models, Specifications and Application
9.15.4 Ajinomoto Recombinant Proteins Revenue and Gross Margin, 2018-2023
9.15.5 Ajinomoto Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer
Table 1. Recombinant Proteins Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Recombinant Proteins Market Restraints
Table 3. Recombinant Proteins Market Trends
Table 4. Recombinant Proteins Industry Policy
Table 5. Global Recombinant Proteins Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Recombinant Proteins Revenue Market Share by Company (2018-2023)
Table 7. Global Recombinant Proteins Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Recombinant Proteins Mergers & Acquisitions, Expansion Plans
Table 9. Global Recombinant Proteins Manufacturers Product Type
Table 10. China Recombinant Proteins Revenue by Company (2018-2023) & (US$ million)
Table 11. China Recombinant Proteins Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Recombinant Proteins Upstream (Raw Materials)
Table 13. Global Recombinant Proteins Typical Customers
Table 14. Recombinant Proteins Typical Distributors
Table 15. By Type, Global Recombinant Proteins Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Recombinant Proteins Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Recombinant Proteins Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Recombinant Proteins Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Recombinant Proteins Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Recombinant Proteins Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Recombinant Proteins Revenue Market Share, 2018-2029
Table 22. Bio-Techne Corporation Company Information, Head Office, Market Area and Industry Position
Table 23. Bio-Techne Corporation Company Profile and Main Business
Table 24. Bio-Techne Corporation Recombinant Proteins Models, Specifications and Application
Table 25. Bio-Techne Corporation Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 26. Bio-Techne Corporation Recent Developments
Table 27. Abcam PLC Company Information, Head Office, Market Area and Industry Position
Table 28. Abcam PLC Company Profile and Main Business
Table 29. Abcam PLC Recombinant Proteins Models, Specifications and Application
Table 30. Abcam PLC Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 31. Abcam PLC Recent Developments
Table 32. Merck KGaA Company Information, Head Office, Market Area and Industry Position
Table 33. Merck KGaA Company Profile and Main Business
Table 34. Merck KGaA Recombinant Proteins Models, Specifications and Application
Table 35. Merck KGaA Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 36. Merck KGaA Recent Developments
Table 37. Miltenyi Biotec Company Information, Head Office, Market Area and Industry Position
Table 38. Miltenyi Biotec Company Profile and Main Business
Table 39. Miltenyi Biotec Recombinant Proteins Models, Specifications and Application
Table 40. Miltenyi Biotec Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 41. Miltenyi Biotec Recent Developments
Table 42. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position
Table 43. Thermo Fisher Scientific Company Profile and Main Business
Table 44. Thermo Fisher Scientific Recombinant Proteins Models, Specifications and Application
Table 45. Thermo Fisher Scientific Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 46. Thermo Fisher Scientific Recent Developments
Table 47. ACROBiosystems Company Information, Head Office, Market Area and Industry Position
Table 48. ACROBiosystems Company Profile and Main Business
Table 49. ACROBiosystems Recombinant Proteins Models, Specifications and Application
Table 50. ACROBiosystems Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 51. ACROBiosystems Recent Developments
Table 52. Sino Biological Company Information, Head Office, Market Area and Industry Position
Table 53. Sino Biological Company Profile and Main Business
Table 54. Sino Biological Recombinant Proteins Models, Specifications and Application
Table 55. Sino Biological Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 56. Sino Biological Recent Developments
Table 57. Cytiva Company Information, Head Office, Market Area and Industry Position
Table 58. Cytiva Company Profile and Main Business
Table 59. Cytiva Recombinant Proteins Models, Specifications and Application
Table 60. Cytiva Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 61. Cytiva Recent Developments
Table 62. Eurogentec Company Information, Head Office, Market Area and Industry Position
Table 63. Eurogentec Company Profile and Main Business
Table 64. Eurogentec Recombinant Proteins Models, Specifications and Application
Table 65. Eurogentec Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 66. Eurogentec Recent Developments
Table 67. GenScript Biotech Corporation Company Information, Head Office, Market Area and Industry Position
Table 68. GenScript Biotech Corporation Company Profile and Main Business
Table 69. GenScript Biotech Corporation Recombinant Proteins Models, Specifications and Application
Table 70. GenScript Biotech Corporation Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 71. GenScript Biotech Corporation Recent Developments
Table 72. Reprocell Company Information, Head Office, Market Area and Industry Position
Table 73. Reprocell Company Profile and Main Business
Table 74. Reprocell Recombinant Proteins Models, Specifications and Application
Table 75. Reprocell Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 76. Reprocell Recent Developments
Table 77. BPS Bioscience Company Information, Head Office, Market Area and Industry Position
Table 78. BPS Bioscience Company Profile and Main Business
Table 79. BPS Bioscience Recombinant Proteins Models, Specifications and Application
Table 80. BPS Bioscience Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 81. BPS Bioscience Recent Developments
Table 82. Abnova Corporation Company Information, Head Office, Market Area and Industry Position
Table 83. Abnova Corporation Company Profile and Main Business
Table 84. Abnova Corporation Recombinant Proteins Models, Specifications and Application
Table 85. Abnova Corporation Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 86. Abnova Corporation Recent Developments
Table 87. ProSpec Tany TechnoGene Company Information, Head Office, Market Area and Industry Position
Table 88. ProSpec Tany TechnoGene Company Profile and Main Business
Table 89. ProSpec Tany TechnoGene Recombinant Proteins Models, Specifications and Application
Table 90. ProSpec Tany TechnoGene Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 91. ProSpec Tany TechnoGene Recent Developments
Table 92. Ajinomoto Company Information, Head Office, Market Area and Industry Position
Table 93. Ajinomoto Company Profile and Main Business
Table 94. Ajinomoto Recombinant Proteins Models, Specifications and Application
Table 95. Ajinomoto Recombinant Proteins Revenue and Gross Margin, 2018-2023
Table 96. Ajinomoto Recent Developments
List of Figure
Figure 1. Recombinant Proteins Picture
Figure 2. Global Recombinant Proteins Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Recombinant Proteins Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Recombinant Proteins Market Share of Global
Figure 5. Global Recombinant Proteins Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Recombinant Proteins Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Recombinant Proteins Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Recombinant Proteins Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Recombinant Proteins Industry Chain
Figure 10. Hormones
Figure 11. Growth Factors
Figure 12. Cytokines
Figure 13. Plasma Protein Factor
Figure 14. Recombinant Metabolic Enzymes
Figure 15. Immune Checkpoint Regulators
Figure 16. Others
Figure 17. By Type, Global Recombinant Proteins Revenue, 2018-2029, US$ Million
Figure 18. By Type, Global Recombinant Proteins Revenue Market Share, 2018-2029
Figure 19. Biopharmaceutical Companies
Figure 20. Academic and Research Institutes
Figure 21. Contract Research Organizations
Figure 22. By Application, Global Recombinant Proteins Revenue, 2018-2029, US$ Million
Figure 23. By Application, Global Recombinant Proteins Revenue Market Share, 2018-2029
Figure 24. By Region, Global Recombinant Proteins Revenue Market Share, 2018-2029
Figure 25. North America Recombinant Proteins Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country, North America Recombinant Proteins Revenue Market Share, 2018-2023
Figure 27. Europe Recombinant Proteins Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country, Europe Recombinant Proteins Revenue Market Share, 2018-2023
Figure 29. Asia Pacific Recombinant Proteins Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. By Country/Region, Asia Pacific Recombinant Proteins Revenue Market Share, 2018-2023
Figure 31. South America Recombinant Proteins Revenue & Forecasts, 2018-2029, US$ Million
Figure 32. By Country, South America Recombinant Proteins Revenue Market Share, 2018-2023
Figure 33. Middle East & Africa Recombinant Proteins Revenue & Forecasts, 2018-2029, US$ Million
Figure 34. U.S. Recombinant Proteins Revenue, 2018-2029, (US$ Million)
Figure 35. By Company, U.S. Recombinant Proteins Market Share, 2018-2023
Figure 36. By Type, U.S. Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 37. By Application, U.S. Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 38. Europe Recombinant Proteins Revenue, 2018-2029, (US$ Million)
Figure 39. By Company, Europe Recombinant Proteins Market Share, 2018-2023
Figure 40. By Type, Europe Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 41. By Application, Europe Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 42. China Recombinant Proteins Revenue, 2018-2029, (US$ Million)
Figure 43. By Company, China Recombinant Proteins Market Share, 2018-2023
Figure 44. By Type, China Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 45. By Application, China Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 46. Japan Recombinant Proteins Revenue, 2018-2029, (US$ Million)
Figure 47. By Company, Japan Recombinant Proteins Market Share, 2018-2023
Figure 48. By Type, Japan Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 49. By Application, Japan Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 50. South Korea Recombinant Proteins Revenue, 2018-2029, (US$ Million)
Figure 51. By Company, South Korea Recombinant Proteins Market Share, 2018-2023
Figure 52. By Type, South Korea Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 53. By Application, South Korea Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 54. Southeast Asia Recombinant Proteins Revenue, 2018-2029, (US$ Million)
Figure 55. By Company, Southeast Asia Recombinant Proteins Market Share, 2018-2023
Figure 56. By Type, Southeast Asia Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 57. By Application, Southeast Asia Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 58. India Recombinant Proteins Revenue, 2018-2029, (US$ Million)
Figure 59. By Company, India Recombinant Proteins Market Share, 2018-2023
Figure 60. By Type, India Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 61. By Application, India Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 62. Middle East & Asia Recombinant Proteins Revenue, 2018-2029, (US$ Million)
Figure 63. By Company, Middle East & Asia Recombinant Proteins Market Share, 2018-2023
Figure 64. By Type, Middle East & Asia Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 65. By Application, Middle East & Asia Recombinant Proteins Revenue Market Share, 2022 VS 2029
Figure 66. Research Methodology
Figure 67. Breakdown of Primary Interviews
Figure 68. Bottom-up Approaches
Figure 69. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|